PL3641735T3 - Kompozycja farmaceutyczna tabletki zawierająca bilastynę w postaci 3 i rozpuszczalny w wodzie wypełniacz - Google Patents
Kompozycja farmaceutyczna tabletki zawierająca bilastynę w postaci 3 i rozpuszczalny w wodzie wypełniaczInfo
- Publication number
- PL3641735T3 PL3641735T3 PL18827035T PL18827035T PL3641735T3 PL 3641735 T3 PL3641735 T3 PL 3641735T3 PL 18827035 T PL18827035 T PL 18827035T PL 18827035 T PL18827035 T PL 18827035T PL 3641735 T3 PL3641735 T3 PL 3641735T3
- Authority
- PL
- Poland
- Prior art keywords
- water
- tablet composition
- pharmaceutical tablet
- soluble filler
- bilastine form
- Prior art date
Links
- ACCMWZWAEFYUGZ-UHFFFAOYSA-N bilastine Chemical group N=1C2=CC=CC=C2N(CCOCC)C=1C(CC1)CCN1CCC1=CC=C(C(C)(C)C(O)=O)C=C1 ACCMWZWAEFYUGZ-UHFFFAOYSA-N 0.000 title 1
- 239000000945 filler Substances 0.000 title 1
- 239000007916 tablet composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201711045443 | 2017-12-18 | ||
| EP18154203.6A EP3470062B1 (en) | 2017-12-18 | 2018-01-30 | Pharmaceutical tablet composition comprising bilastine polymorphic form 3 and magnesium aluminometasilicate |
| IN201811041577 | 2018-11-02 | ||
| PCT/EP2018/085448 WO2019097091A1 (en) | 2017-12-18 | 2018-12-18 | Pharmaceutical tablet composition comprising bilastine form 3 and a water-soluble filler |
| EP18827035.9A EP3641735B1 (en) | 2017-12-18 | 2018-12-18 | Pharmaceutical tablet composition comprising bilastine form 3 and a water-soluble filler |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3641735T3 true PL3641735T3 (pl) | 2021-09-06 |
Family
ID=66539417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18827035T PL3641735T3 (pl) | 2017-12-18 | 2018-12-18 | Kompozycja farmaceutyczna tabletki zawierająca bilastynę w postaci 3 i rozpuszczalny w wodzie wypełniacz |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP3641735B1 (pl) |
| ES (2) | ES2864176T3 (pl) |
| PL (1) | PL3641735T3 (pl) |
| WO (1) | WO2019097091A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119745892A (zh) * | 2023-09-27 | 2025-04-04 | 南京迈诺威医药科技有限公司 | 含有别孕烷醇酮衍生物的药物组合物及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2124167B1 (es) | 1996-06-04 | 1999-09-16 | Espanola Prod Quimicos | Nuevos derivados del bencimidazol con actividad antihistaminica. |
| NZ536551A (en) | 2002-04-19 | 2006-08-31 | Faes Farma S | Preparation of polymorphous cyrstalline form, known as bilastine, and its antihistaminic and antiallergenic use |
| CZ307500B6 (cs) | 2012-08-15 | 2018-10-24 | Zentiva, K.S. | Způsob přípravy derivátu 2-methyl-2´-fenylpropionové kyseliny využívající nové intermediáty |
| SK7066Y1 (sk) | 2014-01-29 | 2015-03-03 | Zentiva Ks | Kryštalický dihydrát bilastínu |
| CN104398481A (zh) | 2014-10-29 | 2015-03-11 | 万全万特制药江苏有限公司 | 比拉斯汀口崩片及其制备方法 |
| SI3327012T1 (sl) | 2015-07-24 | 2021-10-29 | Urquima Sa | Kristalinične oblike bilastina in postopki za pripravo le-teh |
| WO2017167949A1 (en) | 2016-04-01 | 2017-10-05 | Krka, D.D., Novo Mesto | Crystalline forms of bilastine |
| CN106692090A (zh) | 2017-02-14 | 2017-05-24 | 万全万特制药（厦门）有限公司 | 比拉斯汀片及其制备方法 |
-
2018
- 2018-12-18 PL PL18827035T patent/PL3641735T3/pl unknown
- 2018-12-18 WO PCT/EP2018/085448 patent/WO2019097091A1/en not_active Ceased
- 2018-12-18 ES ES18827035T patent/ES2864176T3/es active Active
- 2018-12-18 EP EP18827035.9A patent/EP3641735B1/en active Active
- 2018-12-18 ES ES201990076A patent/ES2773756R1/es not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| ES2773756R1 (es) | 2021-04-12 |
| EP3641735B1 (en) | 2021-02-24 |
| WO2019097091A1 (en) | 2019-05-23 |
| ES2864176T3 (es) | 2021-10-13 |
| ES2773756A2 (es) | 2020-07-14 |
| EP3641735A1 (en) | 2020-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201905098B (en) | A novel isoindoline derivative, a pharmaceutical composition and use thereof | |
| IL269061A (en) | A pharmaceutical preparation containing Selexifag | |
| PL3426348T3 (pl) | Pochodna 3-dezoksylowa i jej kompozycje farmaceutyczne | |
| IL271226A (en) | medical preparation | |
| PT3606511T (pt) | Composição farmacêutica compreendendo mesilato de lenvatinib | |
| IL273704A (en) | Pharmaceutical bilayer tablet formulations | |
| PL3525769T3 (pl) | Tabletka ulegająca rozpadowi w jamie ustnej zawierająca burlulipazę i wytworzona z niej kompozycja farmaceutyczna | |
| PL3658122T3 (pl) | Kompozycja farmaceutyczna zawierająca sakubitryl i walsartan | |
| ZA202008034B (en) | Ivosidenib forms and pharmaceutical compositions | |
| PL3486233T3 (pl) | Słabo rozpuszczalny kompleks lub jego solwat, kompozycja farmaceutyczna i jej zastosowanie | |
| PL3326619T3 (pl) | Stałe doustne kompozycje farmaceutyczne zawierające tenofowir i emtrycytabinę | |
| SMT202200281T1 (it) | Formulazione farmaceutica liofilizzata e suo utilizzo | |
| PL3601277T3 (pl) | Preparat farmaceutyczny | |
| PL3641735T3 (pl) | Kompozycja farmaceutyczna tabletki zawierająca bilastynę w postaci 3 i rozpuszczalny w wodzie wypełniacz | |
| IL275144A (en) | Pharmacy preparation | |
| PT3511001T (pt) | Formulação de comprimido e cápsula contendo pirfenidona | |
| ZA201808201B (en) | A plant-derived medicinal composition | |
| IL254953A0 (en) | Deodorant composition and deodorant product containing a deodorant composition | |
| GB2564515B (en) | Pharmaceutical composition and a method for manufacturing the same | |
| ZA201801904B (en) | A pharmaceutical composition | |
| GB201713920D0 (en) | Pharmaceutical compositions and uses thereof | |
| ZA201903341B (en) | Pharmaceutical compositions and uses thereof | |
| GB201706330D0 (en) | A pharmaceutical composition | |
| PL3592333T3 (pl) | Kompozycja farmaceutyczna zawierająca racekadotryl i sposób jej otrzymywania | |
| GB201812022D0 (en) | Pharmaceutical methods and compositions |